Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine the effectiveness and safety of azacitidine
in the treatment of Taiwanese subjects with higher-risk Myelodysplastic Syndrome (MDS).